Skip to main content

Peer Review reports

From: Treatment persistence to tolvaptan in patients with autosomal dominant polycystic kidney disease: a secondary use of data analysis of patients in the IMADJIN® dataset

Original Submission
10 Aug 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
27 Sep 2021 Reviewed Reviewer Report - Hyunsuk Kim
27 Sep 2021 Reviewed Reviewer Report
19 Oct 2021 Author responded Author comments - Mark Thomas
Resubmission - Version 4
19 Oct 2021 Submitted Manuscript version 4
22 Oct 2021 Author responded Author comments - Mark Thomas
Resubmission - Version 5
22 Oct 2021 Submitted Manuscript version 5
1 Nov 2021 Reviewed Reviewer Report
4 Nov 2021 Reviewed Reviewer Report - Hyunsuk Kim
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
8 Nov 2021 Editorially accepted
2 Dec 2021 Article published 10.1186/s12882-021-02607-4

You can find further information about peer review here.

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us